Novo's Ozempic, Wegovy linked to potential eye problem? Not so fast, analysts say

Novo's Ozempic, Wegovy linked to potential eye problem? Not so fast, analysts say

Source: 
Fierce Pharma
snippet: 

Novo Nordisk’s massively successful GLP-1 analog semaglutide, the active ingredient in the popular diabetes and obesity meds Ozempic and Wegovy, may be linked to a vision loss disorder, a new study suggests. But one team of analysts cautioned against reading too much into the analysis.